CD163+ M2c-like macrophages predominate in renal biopsies from patients with lupus nephritis by unknown
RESEARCH ARTICLE Open Access
CD163+ M2c-like macrophages
predominate in renal biopsies from
patients with lupus nephritis
Gregor Olmes1, Maike Büttner-Herold1, Fulvia Ferrazzi2, Luitpold Distel3, Kerstin Amann1 and Christoph Daniel1*
Abstract
Background: The role of macrophages in the pathogenesis of lupus nephritis, in particular their differentiation to a
certain subtype (e.g., M1- or M2-like) modulating the inflammatory reaction, is unknown. Here we investigated
whether the differentiation in M1- or M2-like macrophages depends on the stage of lupus nephritis and whether
this correlates with clinical parameters.
Method: Using immunohistochemical analysis we analyzed renal biopsies from 68 patients with lupus nephritis
(ISN/RPS classes II–V) for infiltration with M1-like (iNOS+/CD68+), M2a-like (CD206+/CD68+), M2c-like macrophages
(CD163+/CD68+), and FoxP3+ regulatory T-cells. In addition, clinical parameters at the time of renal biopsy, i.e.,
blood pressure, proteinuria and serum urea were correlated with the macrophage infiltration using the Spearman
test.
Results: The mean number of CD68+ macrophages was related to the diagnosed ISN/RPS class, showing the
highest macrophage infiltration in biopsies with diffuse class IV and the lowest number in ISN/RPS class V. In all
ISN/RPS classes we detected more M2c-like CD163+/CD68+ than M2a-like CD206+/CD68+ cells, while M1-
macrophages played only a minor role. Cluster analysis using macrophage subtype numbers in different renal
compartments revealed three main clusters showing cluster 1 dominated by class V. Clusters 2 and 3 were
dominated by lupus class IV indicating that this class can be further differentiated by its macrophage population.
The number of tubulointerstitial FoxP3+ cells correlated with all investigated macrophage subtypes showing the
strongest association to numbers of M2a-like macrophages. Kidney function, as assessed by serum creatinine and
serum urea, correlated positively with the number of total CD68+, M2a-like and M2c-like macrophages in the
tubulointerstitium. In addition, total CD68+ and M2c-like macrophage numbers highly correlated with Austin
activity score. Interestingly, in hypertensive lupus patients only the number of M2a-like macrophages was
significantly increased compared to biopsies from normotensive lupus patients.
Conclusion: M2-like macrophages are the dominant subpopulation in human lupus nephritis and particularly, M2a
subpopulations were associated with disease progression, but their role in disease progression remains unclear.
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Background
Lupus nephritis is the most relevant manifestation of a
heterogeneous group of autoimmune disorders appear-
ing in up to 60 % of patients with systemic lupus erythe-
matosus (SLE), with varying degrees of renal
involvement [1]. Currently, according to the Inter-
national Society of Nephrology/Renal Pathology Society
(ISN/RPS) system lupus nephritis is classified into six
different classes with subclasses, using characteristic
histological findings, i.e., class I, minimal mesangial
lupus nephritis; class II, mesangial proliferative lupus
nephritis; class III, focal lupus nephritis; class IV: diffuse
segmental or global lupus nephritis; class V, membran-
ous lupus nephritis, and class VI, advanced sclerosing
lupus nephritis [2]. Major mechanisms initiating the in-
flammatory response in lupus nephritis are the produc-
tion of autoantibodies and complement activation, but
cellular immune mechanisms mediated through infiltrat-
ing mononuclear cells including macrophages have an
important role in amplification and progression of renal
injury in SLE [3]. Much work has been done to elucidate
the pathophysiology of and optimal therapy for SLE, fo-
cused on the role of autoimmune B cells, T cells, and
plasma cells. Recently, it has become evident, that mac-
rophages are also important players in the pathogenesis
of lupus nephritis. Fc-receptor-bearing myeloid cells, in-
cluding macrophages, are responsible for triggering mur-
ine lupus nephritis [4]. Macrophages are involved in the
clearance of apoptotic cells, which is known to be ineffi-
cient in SLE patients, resulting in the presence of, e.g.,
nuclear antigens that elicit autoantibody production [5].
In addition, macrophages activate other immune cells in
inflammatory diseases by secretion of different cytokines
[6]. Macrophages comprise a heterogeneous population
of cells with different phenotypes and functions [7]. In
the past macrophages were identified as promoting the
progression of kidney disease. Macrophage-depleting
strategies or interventions that interact with the macro-
phage chemokine system have been successful in ameli-
orating different inflammatory kidney diseases [8–11],
including models for lupus nephritis [12–16]. Similar to
T cells, macrophages can polarize to a specific subtype
with completely opposed functions ranging from pro-
inflammatory to anti-inflammatory or pro-fibrotic
actions. Macrophage subtypes can be characterized by
investigation of marker profiles and by measuring the
cytokine expression. The latter method is more precise
but is restricted to in vitro assays. A first classification of
macrophage subtypes has been suggested by Mantovani
et al. [17]. In this simplified classification, macrophages
can be divided into two major classes: the classical
activated M1-like macrophages, representing a pro-
inflammatory type expressing the marker inducible nitric
oxide synthase (iNOS) [18] and the alternatively
activated M2-like-macrophages, which can be subdi-
vided into M2a-like macrophages that are involved in re-
pair and progression of fibrosis [19], M2b-like
macrophages that are inducible by immune complexes
and lipopolysaccharide (LPS) regulating immune re-
sponse [20], and M2c-like macrophages exerting anti-
inflammatory and pro-fibrotic actions [21].
Despite the investigation of macrophage polarization
in different lupus mouse models [13, 22–24] and exten-
sive discussion of the possible contribution of macro-
phage subtype to disease pathogenesis in human lupus
nephritis [25], there are no data on the frequency of dif-
ferent macrophage subpopulations in human lupus
nephritis. Therefore, we investigated renal biopsies from
a cohort of 68 patients with SLE (ISN/RPN classes II–V)
for macrophage subpopulations using immunohisto-
chemical and cluster analysis.
In addition, infiltration of macrophage subtypes was
correlated with renal morphological changes and clinical
parameters to elucidate a potential impact of macro-
phage frequency and polarization on disease progression.
To investigate the immune modulatory function of mac-
rophages in lupus nephritis we also performed immuno-
histochemical analysis of forkhead-box-protein P3
(FoxP3)-positive T cells in renal biopsies.
Methods
Renal tissue specimens
In our study we analyzed macrophage polarization in 68
cases of lupus nephritis that were allocated to SLE clas-
ses II–IV according to the ISN-RPS [2]. All diagnoses
were made by expert nephropathologists. An overview
of the composition and clinical data for the patients with
lupus nephritis is provided in Table 1.
The use of formalin-fixed paraffin-embedded (FFPE)
material from the archive of the Department of Nephro-
pathology was approved by the Ethics Committee of the
Friedrich-Alexander-University of Erlangen-Nürnberg,
waiving the need for retrospective consent for the use of
archived rest material (Re.-No. 4415).
More than half of the patients (56 %) received a treat-
ment at the time of biopsy. Most of these treated pa-
tients received glucocorticoids (76 %) and 47 % received
mycophenolate mofetil; 21 % of the treated patients re-
ceived hydroxychloroquine or azathioprin. A few pa-
tients (<8 %) received cyclophosphamide, rituximab or
methotrexate. In addition, most of the treated patients
(85 %) received a combination of different medications.
Immunohistochemical analysis and double-staining
In our study we used iNOS/CD68 as a marker for M1-
like macrophages, which is well-established [19, 25–29].
Furthermore, we used CD206/CD68 to describe an
M2a-like macrophage subtype and CD163/CD68 as a
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marker for an M2c-like subtype, as CD206 is highly
expressed on the surface of M2a-like macrophages and
CD163 is prominent on the surface of M2c-like macro-
phages (as described by Ohlson et al. [30]). For all co-
localization studies kidneys were fixed in formalin,
embedded in paraffin and cut into sections of 2 μm.
Antigen retrieval was done using citrate buffer pH 6 and
by cooking in a pressure cooker for 2.5 minutes. After
blocking with normal goat serum and 1 % blotto, sec-
tions were incubated overnight at 4 °C using the follow-
ing antibodies diluted in 1 % BSA in 50 mM Tris
pH 7.4: iNOS, a rabbit polyclonal antibody against hu-
man iNOS (dilution 1:500) (ab15323; Abcam plc,
Cambridge, UK); CD163, a mouse monoclonal antibody
against human CD163 (dilution 1:500) (NCL-CD163;
Novocastra, Leica Biosystems Newcastle Ltd; Newcastle,
UK); CD206, a mouse monoclonal antibody against
human CD206 (dilution 1:400) (H00004360; Abnova,
Jhongli City, Taiwan); CD68, a mouse monoclonal anti-
body to human CD68 (dilution 1:50) (M0876; Dako
Deutschland GmbH, Hamburg, Germany); and FoxP3, a
monoclonal mouse antibody against FoxP3 (dilution
1:200) (ab236A; Abcam plc). Negative controls for im-
munostaining included either deletion or substitution of
the primary antibody with equivalent concentrations of
an irrelevant murine monoclonal antibody or pre-
immune rabbit IgG. Double staining for CD68 and
CD163, iNOS and CD206 was performed using the Al-
kaline phosphatase detection kit (POLAP-100, Zytomed
Systems GmbH, Berlin, Germany) and Fast red (Sigma-
Aldrich, Deisenhofen, Germany) as a substrate for
CD163, iNOS and CD206 detection and Fast blue
(Sigma-Aldrich) as a substrate for CD68 detection. For
the FoxP3 double-staining with macrophage markers,
the retrieval cooking time was extended to 5 minutes
and Fast red was used to detect FoxP3 and Fast blue for
macrophage markers.
Quantitative and qualitative evaluation of macrophages
and FoxP3+ cells in renal biopsies
CD68+/iNOS+, CD68+/CD206+ and CD68+/CD163+
double-positive, CD68+ cells, and FoxP3-positive cells
were counted in the whole renal biopsy using a light-
microscope at × 400 magnification. Stained sections were
evaluated by counting cells per mm2 using computer
assisted image analysis software (Count, Biomas,
Erlangen, Germany) or by using a grid. Three different
renal compartments were quantified separately: the
glomerulus, the cortical tubulointerstitium and the
medulla.
Histopathological evaluation
Changes in glomerular morphology including mesangial
matrix accumulation and sclerosis were evaluated by a
semi-quantitative glomerulosclerosis score (GSI) and
tubular interstitial changes were graded by the tubular
injury score (TSI) using perjodate acid Schiff (PAS)-
stained paraffin sections as described previously [31].
Interstitial fibrosis and tubular atrophy (IF/TA) was
graded in line with the Banff classification for renal
transplant biopsies [32]. Lupus disease activity and
chronicity in lupus biopsies were graded by the Austin
Table 1 Characteristics of patients with systemic lupus erythematosus
ISN/RPS class
II III IV V Sum/mean
Number of patients 8 13 26 21 68
Age, years 32.6 ± 18.7 32.3 ± 11.9 31.4 ± 14.6 36.7 ± 16.3 33.3 ± 15.0
Male 1 1 4 5 11
Female 7 12 22 16 57
Ratio male/female 0.14 0.08 0.17 0.31 0.19
Hypertensive patients, % 25 31 27 29 28
Diabetic patients, % 13 0 0 10 6
GSI 0.9 ± 0.7* 1.2 ± 0.7* 2.1 ± 0.5 1.1 ± 0.9* 1.3 ± 0.7
TSI 0.8 ± 0.6 1.4 ± 0.7 1.3 ± 0.4 1.0 ± 0.7 1.1 ± 0.6
Crescents, yes/no 0/8* 9/4 20/6 0/21* 29/38
Proteinuria, g/day 2.3 ± 3.2 3.0 ± 3.3 3.3 ± 2.4 4.8 ± 1.8 3.5 ± 2.7
Serum creatinine, mg/dl 0.9 ± 0.5 0.9 ± 0.4 1.0 ± 0.5 1.2 ± 1.0 1.0 ± 0.6
GFR, ml/min 139.5 ± 79.9 74.3 ± 32.4 75.1 ± 26.8 97.9 ± 42.1 95.8 ± 53.4
Austin activity score (0–24) 2.5 ± 0.9* 5.8 ± 1.5* 9.5 ± 4.2 1.7 ± 1.3*† 5.9 ± 4.5
The mean values are presented as mean ± SD
*p < 0.01 vs. ISN/RPS class IV; †p < 0.05 vs. International Society of Nephrology/Renal Pathology Society (ISN/RPS) class III. GFR glomerular filtration rate, GSI
glomerulosclerosis score, TSI tubular injury score
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score [33]. In addition, the percentage of crescent forma-
tion was determined for each biopsy.
Evaluation of retrospective clinical data
Clinical parameters from patients were retrospectively
acquired from the time point of biopsy collection. The
following parameters were included for correlation ana-
lysis of the evaluated macrophage subpopulations and
injury scores using SPSS software: patient age, hyperten-
sion, diabetes, proteinuria, serum creatinine, serum urea,
anti-nuclear antibody (ANA)-titer, anti-double-stranded
DNA (anti-dsDNA) antibody titer, serum cholesterol,
serum protein, and serum C3 and C4 complement.
Statistical analyses
After testing for normal distribution of values using
Kolmogorov-Smirnov test and finding that many data-
sets are not normally distributed, data were analyzed
using the Kruskal-Wallis test and Dunn’s multiple com-
parison test post hoc test for comparison of SLE ISN/
RPS classes. In all tests p < 0.05 was accepted as statisti-
cally significant. Most data are presented as scatter dot
plots and only the ratios of M1-like to M2-like macro-
phages and Fig. 6 are presented as bars, all indicating
the mean ± SEM. Spearman’s test was used to test cor-
relation between renal macrophage infiltration and renal
injury scores or clinical data. Association between
macrophage infiltration and hypertension was tested
using the Mann-Whitney rank test. Statistical analyses
were performed using SPSS for Windows software (ver-
sion 19.0 SPSS, IBM, Munich, Germany) or GraphPad
Prism 5 for Windows software (version 5.02, GraphPad
software Inc., San Diego, CA, USA).
Hierarchical cluster analysis (Euclidean distance,
complete linkage) using data for macrophage counts per
area in the glomeruli, cortex and medulla was performed
in R software environment version 3.2.1 (R Core Team
(2015) (R: a language and environment for statistical
computing, R Foundation for Statistical Computing,
Vienna, Austria (http://www.R-project.org/)). Prior to
analysis three patients with missing values for macro-
phage counts were excluded and values of macrophage
counts per area were standardized by calculating Z
scores. Ten clusters of patients have been identified by
cutting the resulting dendrogram.
Results
Characteristics of SLE patients with ISN/RPS class II–V
In this study biopsies from SLE patients with ISN/RPS
class II-V were included (Table 1). Most of these patients
were female (84 %). The proportion of male patients in
the different SLE classes was not significantly different
and the male-to-female ratio varied from 0.08 in class III
to 0.31 in ISN/RPS class V (Table 1). In addition, the
mean age of the SLE patients in this study at the time of
biopsy was about 30 years in all four classes investigated
(Table 1).
Hypertension was noted in 25–31 % of all patients.
Diabetes was diagnosed only in a small number of pa-
tients with lupus who were allocated to ISN/RPS classes
II and V. Renal function as assessed by serum creatinine,
GFR and proteinuria varied widely within the ISN/RPS
classes and therefore no significant differences were
noted. There were no significant differences in any of
the other criteria among patients in the different SLE
classes investigated (Table 1). Evaluation of histopatho-
logical changes revealed significantly higher glomerulo-
sclerosis in ISN/RPS class IV compared to all other
investigated groups. However, glomerulosclerosis was
comparable in ISN/RPS classes II, III and V (Table 1). In
contrast, tubulointerstitial changes (TSI) (Table 1) were
similar in all classes. Crescent formation was absent in
ISN/RPS classes II and V and class IV biopsies had the
highest prevalence of crescent formation (Table 1). The
Austin activity index was highest in class IV followed by
class III and was significantly lower in all classes com-
pared to class IV (Table 1).
Macrophage number and ratio of polarized macrophages
is dependent on ISN/RPS class
First, we analyzed total CD68+ macrophage infiltration
in all four investigated SLE ISN/RPS classes. There was
correlation between the number of infiltrating macro-
phages in the glomerular and tubulointerstitial compart-
ments and SLE ISN/RPS class. The number of total
CD68+ macrophages per glomerular area was greatest in
class IV renal biopsies, with mean macrophage numbers
about 2.5 times higher compared to SLE ISN/RPS class
V (Fig. 1a; p < 0.001) and about 2.4 times higher com-
pared to SLE ISN/RPS class II (Fig. 1a; p < 0.05). The
fewest CD68+ glomerular macrophages were detected in
biopsies from patients with SLE ISN/RPS class V, for
which the mean was more than 2.0 times lower com-
pared to values in patients with SLE ISN/RPS class III
(Fig. 1a; p < 0.01). Differences in total macrophage infil-
tration in the tubulointerstitial compartment were less
pronounced, with approximately two-fold maximal dif-
ferences in mean values (Fig. 1b). However, there were
significant differences when making the same compari-
sons of SLE ISN/RPS classes in relation to glomerular
CD68 infiltration (Fig. 1b).
For characterization of macrophage polarization we
performed immunohistochemical double staining com-
bining the pan-macrophage marker CD68 with iNOS to
detect M1-like macrophages (Fig. 2a), with CD206 to de-
tect M2a-like macrophages (Fig. 2b) and with CD163 to
detect M2c-like macrophages (Fig. 2c).
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Fig. 1 Distribution of macrophage subsets in different International Society of Nephrology/Renal Pathology Society (ISN/RPS) classes. Total CD68+, M1-like
inducible nitric oxide synthase (iNOS)+/CD68+ double-positive, M2a-like CD206+/CD68+ double-positive and M2c-like double-positive CD163+/CD68+
macrophages were analyzed in renal biopsies from patient with lupus nephritis ISN/RPS classes II–V using immunohistochemical analysis.
a Total glomerular CD68+ macrophages. b Total tubulointerstitial CD68+ macrophages. c Glomerular M1-like macrophages. d Tubulointerstitial
M1-like-macrophages. e Glomerular M2a-macrophages. f Tubulointerstitial M2a-like macrophages. g Glomerulular M2c-like macrophages.
h Tubulointerstitial M2c-like macrophages. Significant differences between ISN/RPS classes are marked with lines and asterisks (*p < 0.05;
**p < 0.01; ***p < 0.001)
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In all SLE ISN/RPS classes infiltration with iNOS-
positive M1-like macrophages was comparable in the
glomerular compartment but higher in number com-
pared to the tubulointerstitial compartment (Fig. 1c). In
the tubulointerstitial compartment M1-like macrophages
were most prevalent in SLE ISN/RPS class IV biopsies,
with significantly greater numbers compared to renal
biopsies from patients with class II disease (Fig. 1d,
p < 0.01). The smallest mean number of M1-like
macrophages was observed in SLE ISN/RPS class II
renal biopsies, and this was significantly smaller than
the number of M1-like macrophages in class V renal
biopsies (Fig. 1d; p < 0.05). There were also few
M2a-like CD206+ macrophages in the glomeruli but
slightly more in the tubulointerstitial compartment
compared to M1-like macrophages (Fig. 1c-f ). When
comparing SLE ISN/RPS classes, significantly more
M2a-like macrophages were found only in class IV
vs. V (p < 0.05; Fig. 1f ). The CD163+ M2c-like
macrophage was the dominant subtype in all investi-
gated SLE classes (Fig. 1). The numbers of M2c-like
macrophages within the tubulointerstium were sig-
nificantly different between the investigated ISN/RPS
classes (Fig. 1h). However, some differences were not
statistically significant due to greater variance within
the glomerular compartment (Fig. 1g).
Interestingly, the ratios of M1-like to M2a-like and
M2c-like macrophages, which are indicators of changes
in the inflammatory milieu, were also dependent on SLE
ISN/RPS class (Fig. 3). The differences in the ratios of
M1/M2a-like macrophages were not significant (Fig. 3a),
but in the tubulointerstitial compartment mean values of
M1/M2a-like ratios had a strong tendency towards
higher ratios that were more than doubled in class IV
and V compared to ISN/RPS classes II and III (Fig. 3b).
Glomerular ratios of M1/M2c-like macrophages were
more than six times lower in SLE ISN/RPS class III and
IV compared to ratios in class V renal biopsies (p < 0.05;
Fig. 3c). However, the ratios of M1/M2c-like macro-
phages in the tubulointerstitium were not significantly
different in the investigated SLE ISN/RPS classes
(Fig. 3d). In addition, we also observed differences in
M2a/M2c-like macrophage ratios. The glomerular M2a/
M2c-like macrophage ratios in SLE ISN/RPS class V was
significantly higher compared to ratios observed in class
IV (p < 0.05; Fig. 3e). In contrast, in the tubulointersti-
tium the M2a/M2c-like macrophage ratio was signifi-
cantly lower in SLE ISN/RPS class IV compared to class
II, indicating compartment-specific differences in the ra-
tios of polarized macrophages (p < 0.05; Fig. 3f ).
Clustering of macrophage subpopulations in different
renal compartments in biopsies from patients with lupus
nephritis
Next we asked if the information on macrophage sub-
types and its frequencies in different renal compart-
ments could be used to confirm the classical
histomorphological classification or is useful for the de-
scription of a new classification. To this aim patients
were clustered on the basis of the macrophage subpopu-
lation profiles (Fig. 4). In the heatmap in the figure each
row corresponds to a patient, while the columns repre-
sent the abundance of different macrophage subtypes in
the renal compartments (glomeruli, tubulointerstitium,
and medulla), visualized by a color code ranging from
blue (low) to red (high). Interestingly, three major
groups with different macrophage subpopulation profiles
Fig. 2 Immunohistochemical double-staining in different International
Society of Nephrology/Renal Pathology Society (ISN/RPS) classes for
macrophage subsets. Representative double-staining for the different
macrophage subsets using immunohistochemical analysis are shown.
a M1-like macrophages (example from ISN/RPS IV biopsy) were
double-positive (violet and violet arrowhead) for inducible nitric oxide
synthase (iNOS) (red) and CD68 (blue and blue arrowheads). b M2a-like
macrophages (example from ISN/RPS IV biopsy) were double-positive
(violet, e.g., violet arrowheads) CD206 (red) and CD68 (blue and blue
arrowheads). c M2c-like macrophages (example from ISN/RPS III) were
double-positive (violet, e.g., viola arrowheads) CD163 (red) and CD68
(blue and blue arrowheads). d Regulatory T cells (example from ISN/RPS
IV biopsy) were positive for forkhead-box-protein P3 (FoxP3) (purple and
purple arrowheads) and M2c-like CD163+ macrophages (blue).
e Negative control using normal mouse IgG (example from ISN/
RPS IV biopsy). f Negative control using secondary antibody only
(example from ISN/RPS IV biopsy)
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were identified by cluster analysis. Each cluster included
patients who could be allocated to more than one ISN/
RPS class. However, two clusters (cluster 1 + 2) partially
reflected the classical histomorphological classification.
Cluster 1 contains more than 50 % of patient biopsies al-
located to classes II and V. This cluster is characterized
by low macrophage infiltration in all renal compart-
ments. Cluster 2 is dominated by patients of lupus ISN/
RPS class IV. It contains nearly 30 % of all ISN/RPS class
IV patients and also some patients of ISN/RPS class II
and III. This cluster is characterized by high infiltration
of M2a and M2c-like macrophages in all renal compart-
ments. In cluster 3 most biopsies are from patients with
lupus nephritis class IV (n = 8), but the frequency was
comparable to classes II and V, when calculated as the
percentage of the respective ISN/RPS class cases in-
cluded in this study. This cluster represents patients
with more M1-like macrophages in the glomeruli, tubuli,
and medulla compared to clusters 1 and 2 (Fig. 4).
Loss of kidney function is associated with increased
macrophage infiltration
There was positive correlation between loss of kidney
function, as assessed by creatinine clearance, serum
creatinine and serum urea, and the number of several
tubulointerstitial macrophage subtypes, but not with
Fig. 3 Ratios for the different macrophage subsets in each International Society of Nephrology/Renal Pathology Society (ISN/RPS) class.
a Glomerular ratio for M1-/M2a-like macrophages. b Tubulointerstitial ratio for M1-/M2a-like macrophages. c Glomerular ratio for M1-/M2c-like
macrophages. d Tubulointerstitial ratio for M1-/M2c-like macrophages. e Glomerular ratio for M2a-/M2c-like macrophages. f Tubulointerstitial ratio
for M2a-/M2c-like macrophages. Significant differences are marked with lines and asterisks (*p < 0.05)
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glomerular macrophage infiltration. There was strongly
significant correlation between serum creatinine and the
number of tubulointerstitial total CD68+ (r = 0.411),
CD206+ M2a-like macrophages (r = 0.441), and CD163+
M2c-like macrophages (r = 0.414) (Table 2).
Furthermore, in this compartment there was positive
correlation between creatinine clearance and the num-
ber of total CD68+ macrophages (r = 0.454) and M2c-
like, CD163+ macrophages (r = 0.617) (Table 2). In
addition, there was correlation between serum urea and
Fig. 4 Clustering of patients with lupus nephritis using frequencies of different macrophage subsets. Patients with diagnosed lupus nephritis
were clustered on the basis of the profiles of macrophage subsets in different renal compartments. International Society of Nephrology/Renal
Pathology Society (ISN/RPS) systemic lupus erythematosus (SLE) classes of biopsies in each cluster are indicated using a color code (pale green
class II, light green class III, olive green class IV, viridian class V). The frequencies of SLE ISN/RPS classes in the clusters are shown as the number of
cases within the cluster per total number of patients allocated to this class in this study. iNOS inducible nitric oxide synthesase
Table 2 Correlation between tubulointerstitial macrophage subpopulations and renal function
Total M1-like M2a-like M2c-like
CD68+ iNOS+/CD68+ CD206+/CD68+ CD163+/CD68+
Creatinine clearance, ml/min (n = 20) r = –0.454* r = 0.064 r = –0.302 r = –0.617**
p = 0.044 p = 0.788 p = 0.209 p = 0.007
Serum creatinine, mg/dl (n = 52) r = 0.411** r = -0.012 r = 0.441** r = 0.414**
p = 0.002 p = 0.931 p = 0.001 p = 0.002
Serum urea, mg/dl (n = 34) r = 0.621** r = 0.042 r = 0.506** r = 0.611**
p < 0.001 p = 0.809 p = 0.002 p < 0.001
Significant correlation *p < 0.05; **p < 0.01. iNOS inducible nitric oxide synthase
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total CD68+ (r = 0.621) and both M2a-like (r = 0.506)
and M2c-like (r = 0.611) tubulointerstitial macrophages.
In contrast, we found no correlation between protein-
uria and the number of any macrophage subtype.
Increased macrophage infiltration is associated with renal
injury and fibrosis
In our cohort of patients with SLE we found that renal in-
jury is associated with most of the investigated macrophage
subtypes. In the tubulointerstitium there was positive correl-
ation between a higher TSI and the number of total CD68+
macrophages (r= 0.328; Fig. 5a) but also with the number of
M2a-like (r= 0.446; Fig. 5c) and M2c-like macrophages (r=
0.420; Fig. 5e) when correlation with the TSI was tested in-
dependently of ISN/RPS lupus class. In contrast, there was
no correlation between the TSI and the number of M1-like
macrophages. Interestingly, there was stronger correlation
with TSI when the analysis was restricted to class V patients
(Fig. 5b, d, f). Sub-analysis of other lupus nephritis (LN)
classes revealed only significant correlation) between TSI
and M2c-like macrophages in ISN/RPS class IV patients (r
= 0.550, p= 0.015). Furthermore, a higher GSI correlated
with the number of most of the investigated macrophage
subtypes within the glomeruli, including total CD68+ mac-
rophages (r= 0.369; Fig. 5g), CD206+ M2a-like macrophages
(r= 0.280; p < 0.05), CD163+ M2c-macrophages (r= 0,333;
p < 0.01) and only weakly with iNOS+ M1-like macrophages
(r= 0.263; p= 0.03). Again, on sub-analysis of LN class V pa-
tients, there was stronger correlation between total CD68+
macrophages and GSI (Fig. 5h). There was weak correlation
between crescent formation (a sign of active glomerular
damage) and the number of glomerular total CD68+ macro-
phages (r = 0.302; p = 0.012) and between crescent forma-
tion and glomerular CD163+ M2c-like macrophages (r
= 0.318, p = 0.008). Interestingly, there was strong posi-
tive correlation between the Austin activity score
(Table 1) and glomerular (r = 0.549; p < 0.001) and
tubulointerstitial (r = 0.550; p < 0.001) CD68+ macro-
phages and M2c-like glomerular (r = 0.382; p = 0.005)
and tubulointerstitial macrophages (r = 0.525; p < 0.001)
but no correlation between Austin score and M1-like
and M2a-like macrophages in either compartment.
Macrophages are also known to exert pro-fibrotic prop-
erties; therefore, we investigated interstitial fibrosis and
tubular atrophy (IFTA) in renal biopsies. The number
of tubulointerstitial M2a-like and M2c-like macro-
phages were similarly correlated (r = 0,360 and 0,355, p
< 0,005) with IFTA.
Correlation of anti-dsDNA antibody titer and complement
C3 and C4 consumption with the number of different
macrophage subtypes
Interestingly, there was positive correlation between
SLE-related anti-dsDNA antibody titers and different
macrophage subpopulations in the glomerular and
tubulointerstitial compartment. There was correlation
between the anti-dsDNA antibody titers and the num-
ber of total CD68+ macrophages only in the glomerular
(r = 0.369; p = 0.035, n = 31) and not in the tubulointer-
stitial compartment. In contrast, correlation between
anti-dsDNA antibody titer and iNOS+ M1 macro-
phages (r = 0.412; p = 0.019, n = 32) was observed only
in the tubulointerstitium. There was comparable correl-
ation between anti-dsDNA antibody titers and the
numbers of glomerular CD163+ M2c-like macrophages
(r= 0.408; p = 0.018, n = 31) and both glomerular (r = 0.374;
p = 0.032, n = 31) and tubulointerstitial CD206+ M2a-like
macrophages (r = 0.467; p = 0.008, n = 31). In patients with
lupus nephritis the plasma levels for complement C3 and
C4 are decreased due to renal complement deposition.
Here, we observed a negative correlation between
plasma complement C3 and the number of total glom-
erular CD68+ macrophages (r = –0.412; p = 0.004, n = 45)
and stronger correlation between complement C3 glom-
erular CD163+ M2c-like macrophages (r = –0.556;
p < 0.001, n = 45). Interestingly, there was negative
correlation between the number of CD163+ M2c-like
macrophages and plasma C4 levels (r = –0.367; p = 0.022,
n = 43). In the tubulointerstitium we observed no correl-
ation between complement C3 or C4 plasma levels and
any macrophage subtype.
Increased M2a-like macrophage infiltration is associated
with hypertension
In biopsies from patients with SLE and clinically diagnosed
hypertension, only the number of total CD206+ M2a-like
macrophages in glomeruli and the tubulointerstitium was
significantly higher than in normotensive patients with SLE
(Fig. 6c, d). This association was restricted to M2a-like
macrophages. There was no association between hyperten-
sion and glomerular and tubulointerstitial total CD68+
macrophages (Fig. 6a, b), M2c-like macrophages (Fig. 6e, f)
or all M1-like macrophages (data not shown).
FoxP3+ T regulatory cells co-localize with different
macrophage subtypes
FoxP3+ regulatory T cells were detected in low numbers
in glomeruli (Fig. 7a). More FoxP3+ cells were found in
the tubulointerstitium (Fig. 7b). In both compartments
the greatest number of FoxP3+ cells was found in SLE
ISN/RPS class IV biopsies (Fig. 7a, b). FoxP3+ cells al-
ways co-located with macrophages, e.g., CD163+ M2c-
like macrophages (Fig. 2d). However, the number of
FoxP3+ T regulatory cells was positively correlated with
all investigated macrophage subpopulations, M1-like
(Fig. 7d), M2a-like (Fig. 7e), M2c-like (Fig. 7f ) and con-
sequently the number of total CD68+ macrophages in
the tubulointerstitial compartment (Fig. 7c).
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Fig. 5 Tubular injury score (TSI) and glomerulosclerosis score (GSI) correlation with macrophage subtypes. TSI and GSI analyzed in renal biopsies
from patients with lupus nephritis correlated with renal total, M2a-like and M2c-like macrophage invasion when analyzed by the Spearman test
independently of the International Society of Nephrology/Renal Pathology Society class (a, c, e, g) and restricted to lupus nephritis (LN) class V
(b, d, f, h). a Correlation between TSI in all patients with LN and total CD68-positive macrophages. b Correlation between TSI in patients with LN
class V and total CD68-positive macrophages. c Correlation between TSI in all patients with LN and M2a-like macrophages. d Correlation between
TSI in patients with LN class V and M2a-like macrophages. e Correlation between TSI in all patients with LN and M2c-like macrophages. f Correlation
between TSI in patients withg LN class V and M2c-like macrophages. g Correlation between GSI in all patients with LN and total CD68-
positive macrophages. h Correlation between GSI and patients with LN class V and total CD68-positive macrophages. Significant correlation is
marked by asterisks (*p < 0.05; **p < 0.01)
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Discussion
Macrophage subpopulations differ in lupus nephritis
ISN/RPS classes
In this study we investigated macrophage subpopulations
in different ISN/RPS classes of lupus nephritis for the
first time. The first major finding in our study is that in-
filtration of macrophage subpopulations differs between
the four investigated lupus nephritis ISN/RPS classes
and is dominated by CD163+ M2c-like macrophages.
Interestingly, macrophage infiltration differs particularly
in the number of M2c-like macrophages; differences
among the investigated ISN/RPS classes in M1-like and
M2a-like macrophage infiltration were only minor. How-
ever, the proportion of M1-like macrophages to M2c-
like macrophages was greater in the glomeruli but not in
the tubulointerstitium of ISN/RPS classes II and V
(Fig. 4, cluster 3) indicating compartment-specific differ-
ences in macrophage subtype composition. Both the sig-
nificant differences in number of macrophage subtypes
and the cluster analysis using the frequencies of macro-
phage subtypes in different renal compartments support
the thesis that the classical ISN/RPS classes for lupus
nephritis can be characterized by a specific macrophage
signature, as single classes dominate the clusters. In
addition, the cluster analysis allows further refinement
in the characterization of a lupus class. For example,
ISN/RPS class IV biopsies can be divided into a pro-
inflammatory subclass with greater involvement of M1-
like macrophages found in cluster 3 and an anti-
inflammatory M2-like dominated subclass collected in
cluster 2. We suggest that cluster 3 may reflect the
macrophage infiltration during initiation of lupus neph-
ritis and chronic alterations in the kidney were found in
cluster 2. However, we did not find any differences in
disease activity when these data were compared with the
Austin activity score.
Why is the M2c-like subtype the dominant macrophage
subtype in human lupus nephritis?
The second major finding is that the predominant
macrophage subtypes are M2-like macrophages. The
dominant macrophage subtype in biopsies from patients
Fig. 6 Association between hypertension and macrophage subtypes. Numbers of total CD68-positive, M2a-like and M2c-like macrophages were analyzed
in normotensive and hypertensive patients with lupus nephritis. a Comparison of glomerular total CD68-positive macrophage infiltration. b Comparison of
tubulointerstitial total CD68-positive macrophage infiltration. c Comparison of glomerular M2a-like macrophage infiltration. d Comparison of tubulointersti-
tial M2a-like macrophage infiltration. e Comparison of glomerular M2c-like macrophage infiltration. f Comparison of tubulointerstitial M2c-like macrophage
infiltration. Significant differences, as assessed by the Mann-Whitney U rank test, are marked by asterisks (*p< 0.013)
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with SLE was the M2c-like subtype, designated as deacti-
vated, remodeling or anti-inflammatory macrophages.
High numbers of CD163+ macrophages in class IV lupus
nephritis were also recently observed by Li et al. [34].
The M1-like macrophage subtype has long been believed
to be a source of pathology in lupus nephritis [25] and
the high levels of IL-6 [35, 36], IFN- [35] and TNF-α
[36] found in patients with lupus nephritis support the
important role of pro-inflammatory M1-like macro-
phages in the pathogenesis of the disease. There are two
possible explanations that could account for the rela-
tively low numbers of M1-like macrophages. First, sam-
pling of human biopsies in early disease is probably
much rarer than in murine biopsies. Therefore, there
may be fewer M1-like macrophages at the first indica-
tion for biopsy in patients compared to mouse models in
which the timinge of sampling is dependent on the ex-
perimental setting and not on the clinical need for diag-
nosis. Second, the small number of pro-inflammatory
M1-like macrophages is probably a consequence of the
immunosuppressive therapy, as nearly all substances that
are used for therapy in our study are known to increase
CD163 expression and thus an M2 phenotype. Gluco-
corticoids, the most frequently used therapy in our
study, have been shown to increase CD163 on fetal mac-
rophages [37], in a lung transplantation model [38], and
in kidney allograft transplantation [39]. Guo et al. de-
scribe a conversion of macrophages into an M2
Fig. 7 Distribution of T regulatory cells and their correlation with macrophage subtypes. The number of forkhead box protein P3 (FoxP3) +
regulatory T cells was analyzed in International Society of Nephrology/Renal Pathology Society (ISN/RPS) lupus classes and correlation tested with
numbers of total CD68+, M1-like, M2a-like and M2c-like macrophages in the tubulointerstitium. a Glomerular FoxP3+ cells in ISN/RPS class II–V.
b Tubulointerstitial FoxP3+ cells in ISN/RPS classs II–V. c Correlation between FoxP3+ cells and tubulointerstitial total CD68+ macrophages.
d Correlation between FoxP3+ cells and tubulointerstitial M1-like macrophages. e Correlation between FoxP3+ cells and tubulointerstitial M2a-like
macrophages. f Correlation between FoxP3+ cells and tubulointerstitial M2c-like macrophages. Significant differences and correlation are marked
by asterisks (*p < 0.05; **p < 0.01)
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phenotype driven by an immunosuppressive regimen
using mycophenolate mofetil [40]. In addition, rituximab
and cyclophosphamide therapy were also shown to up-
regulate CD163 on macrophages [41]. The M2c-like sub-
type is further driven by IL-10 [17], a cytokine that is
highly upregulated in patients with lupus nephritis [36,
42], suggesting this macrophage subtype is highly rele-
vant in this disease. On the other hand, clearing of apop-
totic cells, a frequently observed phenomenon in lupus
nephritis, requires differentiation of macrophages to an
M2c-like phenotype [43]. Furthermore, high concentra-
tions of soluble CD163 released by M2c-like macro-
phages can be found in plasma from patients with SLE
and correlate with the SLE disease activity index [22], in-
dicating that this macrophage subtype is highly induced
in active disease. This is in accordance with our data, es-
tablishing the CD163+ macrophages as the dominant
renal macrophage subtype in human lupus nephritis.
Is infiltration with specific macrophage subpopulations
associated with or causative of renal disease?
The correlation between infiltrating macrophage subpopu-
lations and renal function, injury and lupus-nephritis-
specific pathology was the third major finding. The
relevance of macrophages for the pathogenesis of lupus
nephritis has been shown in several studies [12–16], e.g.,
there is correlation between the numbers of infiltrating
CD68+ macrophages and monocytes and clinical outcome
parameters, such as proteinuria, in human lupus nephritis
[44]. However, the relevance of specific macrophage sub-
populations remained unclear. Interestingly, in our study a
decrease in renal function was associated with an increase
in M2-like macrophages but not in M1-like macrophages.
There was correlation between both M2a-like and M2c-like
macrophages and nearly all markers of renal functional im-
pairment, despite a much lower prevalence of renal M2a-
like macrophages. Loss of kidney function is associated with
increasing kidney fibrosis. Here, we confirmed correlation
between the numbers of M2a-like and M2c-like macro-
phages and TSI, GSI, crescent formation, and IFTA, indi-
cating that both cells types might be involved in
fibrinogenesis. Interestingly, correlation of M2 subtype
macrophage numbers with renal scarring was strongest in
patients in ISN/RPS class V. This class is characterized by
the highest proteinuria levels and reduced kidney function
(Table 1) but relatively low total macrophage numbers
compared to class IV, indicating that M2-like macrophages
are more relevant for disease modulation or progression in
this low-inflammatory state of lupus nephritis class V.
There was also positive correlation between the number of
M1-like macrophages and the GSI, but on a lower level and
with lower significance. Although M2-like macrophages are
known to be immunomodulatory or anti-inflammatory,
there are several studies confirming a role of M2-like
macrophages in disease progression. Our observation that
CD163+ macrophage infiltration was associated with de-
creased renal function was confirmed for other renal dis-
ease like IgA-nephropathy [45] and in patients after kidney
transplantation [46]. However, it remains unclear whether
CD163+ cells are actors of disease progression, or recruited
to counteract this process in order to prevent progressive
inflammation. There are some hints that CD163+ macro-
phages are actively involved in disease progression, as sug-
gested in a study investigating CD163 in skin lesions from
patients with SLE [47]. In addition, both M2a-like [48] and
M2c-like subtypes [49] express transforming growth factor
(TGF)-ß, a well-known pro-fibrotic cytokine which might
well argue for a leading role of both macrophage subtypes
in scarring, as supported by the correlation of M2-like mac-
rophages with IFTA as observed here.
M2a-like macrophage infiltration is associated with
hypertension
Hypertension is a major risk factor for the progression
of renal and cardiovascular diseases and is the primary
cause of mortality in SLE [50]. The exclusive association
of M2a-like macrophages with hypertension as a marker
of disease progression is the fourth major finding. As a
result of chronic kidney disease (CKD) patients fre-
quently develop hypertension. Despite little being known
about the pathogenesis of hypertension in SLE, there are
many studies supporting the involvement of the immune
system [51]. Going in line with this notion, development
of hypertension was prevented in different models by
blocking of macrophage activation using a CCR2 antag-
onist [52] or macrophage depletion [53]. In a recent
study, the IL-6/IL-31-signaling axis was found to be crit-
ical for the pathogenesis of pulmonary arterial hyperten-
sion, with evidence of a strong association with M2-like
macrophage infiltration [54]. Furthermore, vascular re-
modeling induced by angiotensin II was found to be me-
diated by M2-like macrophage polarization via class A
scavenger receptor A activation [55]. Therefore, it ap-
pears possible that the higher numbers of M2a-like mac-
rophages in hypertensive compared to normotensive
patients with SLE indicates functional involvement of
this macrophage subtype in the pathogenesis of hyper-
tension. This hypothesis, however, needs further investi-
gation and validation.
Association between FoxP3+ cells and macrophage
subtypes
FoxP3+ regulatory T cells (Treg) were shown to suppress
inflammatory response by polarizing macrophages to-
wards an M2c-like phenotype via IL-10 [56]. Therefore,
we compared the numbers of macrophage subtypes and
of FoxP3+ Tregs. Surprisingly, there was no exclusive cor-
relation between FoxP3+ Treg and M2c-like macrophages
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in renal biopsies from patients with lupus nephritis, but
simply an association with higher numbers of macro-
phages in general. Therefore, FoxP3+ cells appear to play
a minor role in the induction of M2c-like macrophages.
The use of FoxP3 as a single marker of Treg may not suf-
fice to characterize Treg, as different Treg subpopulations
have recently been described, and an imbalance of differ-
ent types of CD4+ FoxP3+ cells was suggested to be in-
volved in worsening kidney function in renal transplant
rejection [57].
Limitations of the study
Our study has some limitations. Investigating renal biop-
sies from human samples can only represent a snapshot
of the current disease state. Therefore, we have no infor-
mation on the dynamics of macrophage subtypes in early
disease and during disease progression. The classifica-
tion of macrophage subtypes used in this study is very
simple, and may need to be refined in future studies.
Animal studies using three different models for lupus
nephritis identified two different macrophage subtypes
and three different dendritic cell subtypes in diseased
mice, but the dominant macrophage subtype could not
be allocated to M1-like or M2-like macrophages [24].
When we observe the association between macrophage
subtypes and, e.g., kidney injury, kidney function, or
hypertension, it remains unclear whether macrophages
are the cause or the consequence of these pathological
alterations. Therefore, future experimental studies are
needed to address and hopefully clarify these questions.
Conclusions
In conclusion, our data on macrophages in different ISN/
RPS classes of lupus nephritis show that these classes can
be characterized by different macrophage subpopulations
in the renal biopsy. The M2c-like macrophage is the dom-
inant macrophage subpopulation in the tubulointerstitial
compartment of all investigated ISN/RPS lupus classes.
However, in the glomerular compartment the ratios of M1-
like/M2c-like macrophages differ between classes, with
more M1-like/M2c-like macrophages in classes II and V.
Renal injury and function frequently correlated with num-
bers of M2a-like as well as M2c-like macrophages, while
correlations with the number of M1-like macrophages were
rarely found. The M2a-like macrophage subpopulation was
exclusively associated with hypertension in our cohort of
lupus nephritis patients. Hereby, we suggest that especially
M2-like macrophage subpopulations may be important me-
diators of lupus nephritis.
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